Medical Consumables
Capital Equipment
Brands
  • Paxman Invites Scalp Cooling Research Submissions

Paxman Invites Scalp Cooling Research Submissions

Paxman Invites Scalp Cooling Research Submissions
Showcase Your Data. Strengthen the Evidence. Improve Patient Care

Paxman invites healthcare professionals to contribute real‑world data and clinical insights on scalp cooling and chemotherapy‑induced alopecia.

Paxman has launched a global abstract submission form to support healthcare professionals developing research, posters, or case studies related to scalp cooling and chemotherapy-induced alopecia. If you are preparing an abstract for an upcoming congress or considering analysing your centre’s scalp-cooling data, Paxman would be delighted to explore how it can support you.

You can access the submission page here: https://paxmanscalpcooling.com/abstract-submission/

Latest Articles

Nanosonics Trophon3

Nanosonics Trophon3
The launch of trophon3 and trophon2 Plus set a new benchmark in automated HLD for ultrasound transducers, upholding the trophon technology's market leadership position. These launches reflect our commitment to innovation, customer support and ongoing expansion in this important area of infection prevention.

The Scalp Cooling Registry

The Scalp Cooling Registry
Chemotherapy-induced alopecia (CIA) remains one of the most distressing side effects of cancer treatment. While scalp cooling is currently the only regulatory-approved method to reduce CIA, its effectiveness varies, particularly across different chemotherapy regimens and patient profiles. That’s why advancing our scientific understanding of how cooling works (and how we can enhance its impact) is vital.

The Rationale for Ultrasound-Guided IV Access

The Rationale for Ultrasound-Guided IV Access
Why use ultrasound for IV access? Clinical guidelines supporting ultrasound-guided IV placement. Clinical use and special populations. Let’s talk about implementation and the next steps.